Chemical Structure : Atuveciclib
CAS No.: 1414943-88-6
Catalog No.: PC-60537Not For Human Use, Lab Use Only.
Atuveciclib (BAY-1143572) is a potent, highly selective, orally bioavailable CDK9/P-TEFb inhibitor with IC50 of 6 nM for CDK9/CyclinT1.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $128 | In stock | |
10 mg | $198 | In stock | |
25 mg | $328 | In stock | |
50 mg | $528 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Atuveciclib (BAY-1143572) is a potent, highly selective, orally bioavailable CDK9/P-TEFb inhibitor with IC50 of 6 nM for CDK9/CyclinT1.
Atuveciclib displays >150-fold selectivity over CDK1/2/3/5/6/7 (IC50>800 nM), also shows submicromolar inhibitory activity against GSK3α (IC50=45 nM), GSK3β (IC50=87 nM).
Atuveciclib demonstrates antiproliferative activity against HeLa cells (IC50=920 nM) and MOLM‐13 cells (IC50=310 nM).
Atuveciclib exhibits anticancer activity in human AML models.
M.Wt | 387.433 | |
Formula | C18H18FN5O2S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(3-((4-(4-fluoro-2-methoxyphenyl)-1,3,5-triazin-2-yl)amino)benzyl)(imino)(methyl)-l6-sulfanone |
1. Lücking U, et al. ChemMedChem. 2017 Nov 8;12(21):1776-1793.
2. Narita T, et al. Blood. 2017 Aug 31;130(9):1114-1124.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright